abstract |
The present invention relates to an anti-PD-L1 antibody or antigen-binding fragment thereof, a nucleic acid encoding the same, a therapeutic composition thereof, and a method for enhancing T-cell function of upregulating its cell-mediated immune response, For example, for the treatment of tumor immunity, and for its use for the treatment of cancer. |